Quarterly report pursuant to Section 13 or 15(d)

Stock Plans (Tables)

v3.19.1
Stock Plans (Tables)
3 Months Ended
Mar. 31, 2019
Schedule of Stock-based Compensation Expense

The Company’s stock-based compensation expense recognized for the periods presented was as follows:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2019

 

 

2018

 

Stock-based compensation expense by type of award:

 

 

 

 

 

 

 

 

Restricted stock units

 

$

198

 

 

$

218

 

Restricted stock awards

 

 

160

 

 

 

48

 

Machine Box contingent common stock issuances

 

 

704

 

 

 

 

Performance-based stock options

 

 

1,935

 

 

 

 

Stock options

 

 

2,358

 

 

 

2,036

 

Employee stock purchase plan

 

 

152

 

 

 

172

 

Total

 

$

5,507

 

 

$

2,474

 

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2019

 

 

2018

 

Stock-based compensation expense by operating expense grouping:

 

 

 

 

 

 

 

 

Sales and marketing

 

$

243

 

 

$

320

 

Research and development

 

 

1,084

 

 

 

241

 

General and administrative

 

 

4,180

 

 

 

1,913

 

 

 

$

5,507

 

 

$

2,474

 

Schedule of Restricted Stock Award Activity

The Company’s restricted stock award activity for the three months ended March 31, 2019 was as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2018

 

 

72,208

 

 

$

7.26

 

Vested

 

 

(9,621

)

 

$

3.62

 

Unvested at March 31, 2019

 

 

62,587

 

 

$

7.82

 

Schedule of Restricted Stock Unit Activity

The Company’s restricted stock unit activity for the three months ended March 31, 2019 was as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2018

 

 

49,143

 

 

$

12.57

 

Granted

 

 

50,535

 

 

$

5.65

 

Unvested at March 31, 2019

 

 

99,678

 

 

$

9.06

 

 

Schedule of Stock Option Activity

The activity during the three months ended March 31, 2019 related to all other stock options was as follows:

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

 

 

 

 

Exercise

 

 

Contractual

 

Intrinsic

 

 

 

Options

 

 

Price

 

 

Term

 

Value

 

Outstanding at December 31, 2018

 

 

5,154,691

 

 

$

13.78

 

 

 

 

 

 

 

Granted

 

 

432,400

 

 

$

5.66

 

 

 

 

 

 

 

Exercised

 

 

(20,050

)

 

$

1.50

 

 

 

 

 

 

 

Forfeited

 

 

(72,195

)

 

$

12.30

 

 

 

 

 

 

 

Expired

 

 

(28,948

)

 

$

12.70

 

 

 

 

 

 

 

Outstanding at March 31, 2019

 

 

5,465,898

 

 

$

13.21

 

 

8.28 years

 

$

1,058

 

Exercisable at March 31, 2019

 

 

3,016,052

 

 

$

13.71

 

 

7.83 years

 

$

1,026

 

Employee Stock Purchase Plan [Member]  
Summary of Fair Value Assumptions of Stock Purchase Plan

The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the three months ended March 31, 2019 are set forth in the table below:

 

Expected term (in years)

 

0.5 - 2.0

 

Expected volatility

 

51% - 57%

 

Risk-free interest rate

 

1.3% - 2.2%

 

Expected dividend yield

 

 

 

Timebased Stock Option [Member]  
Schedule of Fair Value Assumptions The following assumptions were used to compute the grant date fair values of the Time-Based Options granted during the three months ended March 31, 2019:

Expected term (in years)

 

 

6.0

 

Expected volatility

 

 

68

%

Risk-free interest rate

 

 

2.5

%

Expected dividend yield

 

 

 

 

Performance-based Stock Options [Member]  
Summary of Fair Value Assumptions of Stock Purchase Plan The following assumptions were used in the Monte Carlo simulation model for computing the grant date fair values of the Performance Options granted during the three months ended March 31, 2019:

Estimated volatility

 

 

65

%

Risk-free interest rate

 

 

2.7

%

Dividend yield

 

 

%

Cost of equity

 

 

14

%

 

Schedule of Stock Option Activity

The activity during the three months ended March 31, 2019 related to stock options that are subject to performance-based vesting conditions tied to the future achievement of stock price goals by the Company was as follows:

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

Aggregate

 

 

 

 

 

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

 

 

Options

 

 

Price

 

 

Term

 

 

Value

 

Outstanding at December 31, 2018

 

 

3,167,325

 

 

$

21.25

 

 

 

 

 

 

 

 

 

Granted

 

 

1,449,102

 

 

$

5.67

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(10,296

)

 

$

5.65

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2019

 

 

4,606,131

 

 

$

16.38

 

 

9.35 years

 

 

$

 

Exercisable at March 31, 2019

 

 

 

 

$

 

 

 

 

 

$